Histamine H2-Receptor Antagonism of T-593, an Anti-ulcer Agent: Studies on Aminopyrine Accumulation in Isolated Canine Gastric Mucosal Cells.
-
- Inoie Masukazu
- Research Laboratories, Toyama Chemical Co., Ltd.
-
- Marubuchi Shigeki
- Research Laboratories, Toyama Chemical Co., Ltd.
-
- Arai Hirotoshi
- Research Laboratories, Toyama Chemical Co., Ltd.
Bibliographic Information
- Other Title
-
- Histamine H2-Receptor Antagonism of T-5
Search this article
Abstract
Histamine H2-receptor antagonistic properties of the anti-ulcer agent T-593, (±)-(E)-1-[2hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2[[[5-(methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl)guanidine, were investigated on [14C]aminopyrine accumulation in isolated canine gastric mucosal cells and compared with those of ranitidine and famotidine. The potency of T-593-inhibition of [14C]aminopyrine accumulation stimulated by 10-4 M histamine, with an IC50 value of 1.85× 10-6 M, was approximately 5 times greater than that of ranitidine, but half that of famotidine. T-593 did not affect [14C]aminopyrine accumulation stimulated by carbachol or dibutyryl-cAMP. T-593 depressed the maximal response of the histamine concentration-response curve with a dose-related displacement to the right, indicating that the nature of the H2-receptor antagonism of T-593 was insurmountable and included noncompetitive inhibition. The inhibitory efficacy of T-593 was time-dependent and was retained after the cells were washed. The inhibitory potency of (-)-S-T-593, one of the enantiomers, on the [14C]aminopyrine accumulation stimulated by histamine was approximately twice that of racemic T-593 and it also behaved as an insurmountable H2-receptor antagonist. However, the potency of (+)-R-T-593 was markedly weak. These results suggest that T-593 has H2-receptor antagonism that is insurmountable and this agent slowly associates and dissociates with the receptor in isolated canine gastric mucosal cells and that the specific substance causing H2-receptor antagonism is (-)-S-T-593.
Journal
-
- The Japanese Journal of Pharmacology
-
The Japanese Journal of Pharmacology 78 (3), 313-322, 1998
The Japanese Pharmacological Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679262753792
-
- NII Article ID
- 10008681223
-
- NII Book ID
- AA00691188
-
- COI
- 1:CAS:528:DyaK1cXnslyktLs%3D
-
- ISSN
- 13473506
- 00215198
-
- NDL BIB ID
- 4610820
-
- PubMed
- 9869265
-
- Web Site
- https://ndlsearch.ndl.go.jp/books/R000000004-I4610820
- https://api.elsevier.com/content/article/PII:S0021519819310303?httpAccept=text/xml
- https://api.elsevier.com/content/article/PII:S0021519819310303?httpAccept=text/plain
- https://www.jstage.jst.go.jp/article/jjp/78/3/78_3_313/_pdf
- https://search.jamas.or.jp/link/ui/1999087244
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed